Related Experiment Videos
[Classification and treatment of DIC]
Summary
Disseminated intravascular coagulation (DIC) involves extreme blood clotting. Classifying DIC by coagulation or fibrinolysis dominance aids in selecting appropriate treatments for conditions like sepsis or acute promyelocytic leukemia.
Area of Science:
- Hematology
- Pathophysiology
- Medical Diagnostics
Context:
- Disseminated intravascular coagulation (DIC) is a complex syndrome with severe coagulation activation.
- Clinical outcomes, including bleeding and organ failure, depend on the underlying cause.
- The balance between coagulation and fibrinolysis activation is critical in DIC pathogenesis.
Purpose:
- To classify Disseminated intravascular coagulation (DIC) into distinct types based on coagulation and fibrinolysis patterns.
- To correlate specific DIC subtypes with underlying diseases and clinical manifestations.
- To emphasize the importance of DIC classification for guiding treatment strategies.
Summary:
- DIC is categorized into two main types: predominant coagulation activation (high thrombin-antithrombin III complex [TAT], elevated plasminogen activator inhibitor 1 [PAI]) often seen in sepsis with organ failure, and predominant fibrinolysis activation (high TAT and plasmin-alpha 2 plasmin inhibitor complex [PIC], normal PAI) common in acute promyelocytic leukemia (APL) with bleeding.
- Pre-DIC diagnosis involves monitoring decreasing platelets in sepsis and elevated Fibrinogen Degradation Products (FDP) and D-dimer in APL, leukemia, and cancer.
- Understanding these classifications is crucial for effective DIC management.
Impact:
- Provides a framework for differentiating DIC subtypes, aiding clinicians in tailoring treatment.
- Highlights the link between specific DIC patterns, underlying pathologies, and clinical presentation.
- Improves diagnostic approaches for early detection of pre-DIC states, potentially improving patient outcomes.